Vir Biotechnology recently announced that David Liu will serve as the company's chief medical officer. Before this transition, Liu worked in the same capacity at Nuvation Bio. The staffing change was documented in a regular industry series monitoring executive appointments, promotions, and related workplace shifts. That compilation actively invites sector organizations to submit their recent personnel updates.
Key points
Executive leadership at Vir Biotechnology has expanded with the addition of a new chief m…: Executive leadership at Vir Biotechnology has expanded with the addition of a new chief medical officer.
David Liu brings prior experience as a chief medical officer from his time at Nuvation Bi…: David Liu brings prior experience as a chief medical officer from his time at Nuvation Bio.
Biopharma organizations continue to report executive transitions to a regular tracker cov…: Biopharma organizations continue to report executive transitions to a regular tracker covering sector personnel moves.
Sources checked by our analysis pipeline: 1
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.
And here is our regular feature in which we highlight a different person each week. This time around, we note that Vir Biotechnology hired David Liu as chief medical officer. Previously, he worked at Nuvation Bio, where he held the same position.
But all work and no play can make for a dull chief medical officer.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Rising fuel costs and mounting affordability pressures are driving budget-conscious consumers to snap up entry-level vehicles at an accelerating rate. However, persistent inventory shortages and the complete exit of domestic automakers from the compact sedan market have constrained overall transaction volumes. As affordable new models disappear quickly, unmet demand is spilling directly into the pre-owned market.
Shares of Michael Kors parent company Capri surged following an increase in its annual financial forecasts. The company's market gains came directly after it raised its outlook for the year.
Massive capital allocations toward artificial intelligence infrastructure have forced industry leaders to redirect funds away from dividends and repurchases. This structural pivot marks a historic low point for investor payouts that has not been witnessed in a decade and a half. The strategic shift prioritizes long-term technological dominance over immediate shareholder capital returns.